Private Advisor Group LLC Has $5.21 Million Stake in Cardinal Health, Inc. $CAH

Private Advisor Group LLC lifted its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 36.9% during the first quarter, HoldingsChannel reports. The firm owned 24,643 shares of the company’s stock after acquiring an additional 6,647 shares during the quarter. Private Advisor Group LLC’s holdings in Cardinal Health were worth $5,207,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of CAH. Nordea Investment Management AB boosted its position in Cardinal Health by 328.3% during the 4th quarter. Nordea Investment Management AB now owns 645,436 shares of the company’s stock worth $133,741,000 after acquiring an additional 494,731 shares during the last quarter. Procyon Advisors LLC raised its position in Cardinal Health by 78.7% during the fourth quarter. Procyon Advisors LLC now owns 17,025 shares of the company’s stock worth $3,499,000 after acquiring an additional 7,499 shares in the last quarter. Kornitzer Capital Management Inc. KS lifted its stake in Cardinal Health by 100.8% in the fourth quarter. Kornitzer Capital Management Inc. KS now owns 18,164 shares of the company’s stock valued at $3,733,000 after acquiring an additional 9,120 shares during the last quarter. Bank of Nova Scotia lifted its stake in Cardinal Health by 137.4% in the third quarter. Bank of Nova Scotia now owns 393,474 shares of the company’s stock valued at $61,760,000 after acquiring an additional 227,716 shares during the last quarter. Finally, Swiss Life Asset Management Ltd grew its position in shares of Cardinal Health by 73.3% in the 3rd quarter. Swiss Life Asset Management Ltd now owns 76,736 shares of the company’s stock valued at $12,044,000 after acquiring an additional 32,464 shares during the period. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Performance

CAH opened at $239.36 on Wednesday. The stock has a fifty day moving average of $210.43 and a 200-day moving average of $212.35. Cardinal Health, Inc. has a fifty-two week low of $137.75 and a fifty-two week high of $243.21. The company has a market capitalization of $56.06 billion, a P/E ratio of 36.60, a P/E/G ratio of 1.17 and a beta of 0.49.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. The business had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. Cardinal Health’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same period last year, the firm earned $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, equities research analysts predict that Cardinal Health, Inc. will post 10.76 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be given a $0.5158 dividend. The ex-dividend date is Wednesday, July 1st. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.9%. Cardinal Health’s dividend payout ratio (DPR) is presently 31.50%.

Analyst Upgrades and Downgrades

CAH has been the topic of a number of research analyst reports. Wells Fargo & Company dropped their target price on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a report on Friday, May 1st. TD Cowen boosted their price target on Cardinal Health from $251.00 to $255.00 and gave the stock a “buy” rating in a research report on Friday, May 1st. Evercore dropped their price objective on Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 8th. Bank of America raised their price objective on Cardinal Health from $240.00 to $260.00 and gave the company a “buy” rating in a research report on Thursday, July 2nd. Finally, Weiss Ratings lowered Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a report on Tuesday, May 19th. Fifteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $247.80.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.